Voluntary wheel running in rats receiving doxorubicin: Effects on running activity and cardiac myosin heavy chain

Anticancer Research

Volumn 29, Issue 11, 2009, Pages 4401-4407

  Hydock, David S ^a   Wonders, Karen Y ^b   Schneider, Carole M ^a   Hayward, Reid ^a  

^a UNIVERSITY OF NORTHERN COLORADO   (United States)

^b WRIGHT STATE UNIVERSITY   (United States)

Author keywords

Adriamycin; Anthracylcine; Cardiotoxicity; Exercise

Indexed keywords

DOXORUBICIN; MYOSIN HEAVY CHAIN ALPHA; MYOSIN HEAVY CHAIN BETA;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CARDIOTOXICITY; CONTROLLED STUDY; DOWN REGULATION; FEMALE; HEART; HEART PROTECTION; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RUNNING; SITTING; TREADMILL; TREADMILL EXERCISE; UPREGULATION;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; BEHAVIOR, ANIMAL; DOXORUBICIN; FEMALE; HEART; MOTOR ACTIVITY; MYOCARDIUM; MYOSIN HEAVY CHAINS; ORGAN SIZE; PROTEIN ISOFORMS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 75149170133     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Neilan TG, Jassal DS, Perez-Sanz TM, Raher MJ, Pradhan AD, Buys ES, Ichinose F, Bayne DB, Halpern EF and Weyman AE: Tissue Doppler imaging predicts left ventricular dysfunction and mortality in a murine model of cardiac injury. Eur Heart J 27: 1868-1875, 2006.
2. Belham M, Kruger A, Mepham S, Faganello G and Pritchard C: Monitoring left ventricular function in adults receiving anthracycline-containing chemotherapy. Eur J Heart Fail 9: 409-414, 2007.
3. Lipshultz SE, Lipsitz SR, Sallan SE, Dalton VM, Mone SM, Gelber RD and Colan SD: Chronic progressive cardiac dysfunction years after doxorubicin therapy for childhood acute lymphoblastic leukemia. J Clin Oncol 23: 2629-2636, 2005.
4. Chaiswing L, Cole MP, St Clair DK, Ittarat W, Szweda LI and Oberley TD: Oxidative damage precedes nitrative damage in Adriamycin-induced cardiac mitochondrial injury. Toxicol Pathol 52: 536-547, 2004.
5. Wakasugi S, Fischman AJ, Babich JW, Callahan RJ, Elmaleh DR, Wilkinson R and Stauss HW: Myocardial substrate utilization and left ventricular function in Adriamycin cardiomyopathy. J Nucl Med 34: 1529-1535, 1993.
6. Arola OJ, Saraste A, Pulkki K, Kallajoki M, Parvinen M and Voipio-Pukki LM: Acute doxorubicin cardiotoxicity involves cardiomyocyte apoptosis. Cancer Res 60: 1789-1792, 2000.
7. Hasinoff BB: Dexrazoxane use in the prevention of anthracycline extravasation injury. Future Oncol 2: 15-20, 2006.
8. Cusack BJ, Gambliel H, Musser B, Hadjokas N, Shadle SE, Charlier H and Olson RD: Prevention of chronic anthracycline cardiotoxicity in the adult Fischer 344 rat by dexrazoxane and effects on iron metabolism. Cancer Chemother Pharmacol 58: 517-526, 2006.
9. Tesoriere L, Ciaccio M, Valenza M, Bongiorno A, Maresi E, Albiero R and Livrea MA: Effect of vitamin A administration on resistance of rat heart against doxorubicin-induced cardiotoxicity and lethality. J Pharmacol Exp Ther 269: 430-436, 1994.
10. Breed JG, Zimmerman AN, Dormans JA and Pinedo HM: Failure of the antioxidant vitamin E to protect against Adriamycin-induced cardiotoxicity in the rabbit. Cancer Res 40: 2033-2038, 1980.
11. Agapito MT, Antolin Y, del Brio MT, Lopez-Burillo S, Pablos MI and Recio JM: Protective effect of melatonin against Adriamycin toxicity in the rat. J Pineal Res 31: 23-30, 2001.
12. Ascensao A, Magalhaes J, Soares J, Ferreira R, Neuparth M, Marques F, Oliveira J and Duarte J: Endurance training attenuates doxorubicin-induced cardiac oxidative damage in mice. Int J Cardiol 100: 451-460, 2005.
13. Chicco AJ, Schneider CM and Hayward R: Voluntary exercise protects against acute doxorubicin cardiotoxicity in the isolated perfused rat heart. Am J Physiol Regul Integr Comp Physiol 289: R424-R431, 2005.
14. Chicco AJ, Schneider CM and Hayward R: Exercise training attenuates acute doxorubicin-induced cardiac dysfunction. J Cardiovasc Pharmacol 47: 182-189, 2006.
15. Hydock DS, Lien CY, Schneider CM and Hayward R: Exercise preconditioning protects against doxorubicin-induced cardiac dysfunction. Med Sci Sports Exerc 40: 808-817, 2008.
16. Wonders KY, Hydock DS, Schneider CM and Hayward R: Acute exercise protects against doxorubicin cardiotoxicity. Integr Cancer Ther 7: 147-154, 2008.
17. Burnham TR and Wilcox A: Effects of exercise on physiological and psychological variables in cancer survivors. Med Sci Sports Exerc 34: 1863-1867, 2002.
18. Schneider CM, Hsieh CC, Sprod LK, Carter SD and Hayward R: Effects of supervised exercise training on cardiopulmonary function and fatigue in breast cancer survivors during and after treatment. Cancer 110: 918-925, 2007.
19. Schneider CM, Hsieh CC, Sprod LK, Carter SD and Hayward R: Exercise training manages cardiopulmonary function and fatigue during and following treatment in male cancer survivors. Integrative Cancer Therapies 6: 235-241, 2007
20. Chicco AJ, Hydock DS, Schneider CM and Hayward R: Low-intensity exercise training during doxorubicin treatment protects against cardiotoxicity. J Appl Physiol 100: 519-527, 2006.
21. Hagg U, Andersson I, Naylor AS, Gronros J, Jonsdottir IH, Bergstrom G and Gan LM: Voluntary physical exercise-induced vascular effects in spontaneously hypertensive rats. Clin Sci (Lond) 107: 571-581, 2004.
22. Kingwell BA, Arnold PJ, Jennings GL and Dart AM: The effects of voluntary running on cardiac mass and aortic compliance in Wistar-Kyoto and spontaneously hypertensive rats. J Hypertens 16: 181-185, 1998.
23. Przyklenk K and Groom AC: Effects of exercise frequency, intensity, and duration on revascularization in the transition zone of infarcted rat hearts. Can J Physiol Pharmacol 63: 273-278, 1985.
24. Hydock DS, Lien CY, Schneider CM and Hayward R: Effects of voluntary wheel running on cardiac function and myosin heavy chain in chemically gonadectomized rats. Am J Physiol Heart Circ Physiol 293: H3254-3264, 2007.
25. Jin H, Yang R, Li W, Lu H, Ryan AM, Ogasawara AK, Van Peborgh J and Paoni NF: Effects of exercise training on cardiac function, gene expression, and apoptosis in rats. Am J Physiol Heart Circ Physiol 279: H2994-3002, 2000.
26. Natali AJ, Wilson LA, Peckham M, Turner DL, Harrison SM and White E: Different regional effects of voluntary exercise on the mechanical and electrical properties of rat ventricular myocytes. J Physiol 547: 863-875, 2002.
27. Natali AJ, Turner DL, Harrison SM and White E: Regional effects of voluntary exercise on cell size and contraction-frequency responses in rat cardiac myocytes. J Exp Biol 204: 1191-1199, 2001.
28. Ascensao A, Magalhaes J, Soares JM, Ferreira R, Neuparth MJ, Marques F, Oliveira PJ and Duarte JA: Moderate endurance training prevents doxorubicin-induced in vivo mitochondriopathy and reduces the development of cardiac apoptosis. Am J Physiol Heart Circ Physiol 289: H722-731, 2005.
29. de Beer EL, Bottone AE, van Der Velden J and Voest EE: Doxorubicin impairs crossbridge turnover kinetics in skinned cardiac trabeculae after acute and chronic treatment. Mol Pharmacol 57: 1152-1157, 2000.
30. Krenz M, Sanbe A, Bouyer-Dalloz F, Gulick J, Klevitsky R, Hewett TE, Osinska HE Lorenz, JN Brosseau C, Federico A, Alpert NR, Warshaw DM, Perryman MB, Helmke SM and Robbins J: Analysis of myosin heavy chain functionality in the heart. J Biol Chem 278: 17466-17474, 2003.
31. Korte FS, Herron TJ, Rovetto MJ and McDonald KS: Power output is linearly related to MyHC content in rat skinned myocytes and isolated working hearts. Am J Physiol Heart Circ Physiol 289: H801-812, 2005.
32. Herron TJ and McDonald KS: Small amounts of alpha-myosin heavy chain isoform expression significantly increase power output of rat cardiac myocyte fragments. Circ Res 90: 1150-1152,2002.
33. Tardiff JC, Hewett TE, Factor SM, Vikstrom KL, Robbins J and Leinwand LA: Expression of the beta (slow)-isoform of MHC in the adult mouse heart causes dominant-negative functional effects. Am J Physiol Heart Circ Physiol 278: H412-419, 2000.
34. Talmadge RJ and Roy RR: Electrophoretic separation of rat skeletal muscle myosin heavy-chain isoforms. J Appl Physiol 75: 2337-2340, 1993.
35. Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254, 1976.
36. Noble EG, Moraska A, Mazzeo RS, Roth DA, Olsson MC, Moore RL and Fleshner M: Differential expression of stress proteins in rat myocardium after free wheel or treadmill run training. J Appl Physiol 86: 1696-1701, 1999.
37. Nieman DC: Exercise, infection, and immunity. Int J Sports Med 15(Suppl 3): S131-141, 1994.
38. Pedersen BK and Bruunsgaard H: How physical exercise influences the establishment of infections. Sports Med 19: 393-400, 1995.
39. Gotlieb WH, Bruchim I, Ben-Baruch G, Davidson B, Zeltser A, Andersen A and Olsen H: Doxorubicin levels in the serum and ascites of patients with ovarian cancer. Eur J Surg Oncol 33: 213-215, 2007.
40. Krause MS, Oliveira LP, Jr., Silveira EM, Vianna DR, Rossato JS, Almeida BS, Rodrigues MF, Fernandes A J, Costa JA, Curi R and de Bittencourt PI: MRP1/GS-X pump ATPase expression: is this the explanation for the cytoprotection of the heart against oxidative stress-induced redox imbalance in comparison to skeletal muscle cells? Cell Biochem Funct 25: 23-32, 2007.
41. Jones LW, Eves ND, Courneya KS, Chiu BK, Baracos VE, Hanson J, Johnson L and Mackey JR: Effects of exercise training on antitumor efficacy of doxorubicin in MDA-MB-231 breast cancer xenografts. Clin Cancer Res 11: 6695-6698, 2005.
42. Aragno M, Mastrocola R, Medana C, Catalano MG, Vercellinatto I, Danni O and Boccuzzi G: Oxidative stress-dependent impairment of cardiac-specific transcription factors in experimental diabetes. Endocrinology 147: 5967-5974, 2006.
43. Tokarska-Schlattner M, Wallimann T and Schlattner U: Alterations in myocardial energy metabolism induced by the anti-cancer drug doxorubicin. C R Biol 329: 657-668, 2006.
44. Emter CA, McCune SA, Sparagna GC, Radin MJ and Moore RL: Low-intensity exercise training delays onset of decompensated heart failure in spontaneously hypertensive heart failure rats. Am J Physiol Heart Circ Physiol 289: H2030-2038, 2005.
45. Zhong Y, Reiser PJ and Matlib MA: Gender differences in myosin heavy chain-beta and phosphorylated phospholamban in diabetic rat hearts. Am J Physiol Heart Circ Physiol 285: H2688-2693,2003.
46. Herron TJ, Korte FS and McDonald KS: Loaded shortening and power output in cardiac myocytes are dependent on myosin heavy chain isoform expression. Am J Physiol Heart Circ Physiol 281: H1217-1222, 2001.
47. Pushpalatha K, Nishanth K and Sathyavelu Reddy K: Myocardial antioxidant status and oxidative stress after combined action of exercise training and ethanol in two different age groups of male albino rats. Acta Biol Hung 58: 173-185, 2007.
48. Konhilas JP, Watson PA, Maass A, Boucek DM, Horn T, Stauffer BL, Luckey SW, Rosenberg P and Leinwand LA: Exercise can prevent and reverse the severity of hypertrophic cardiomyopathy. Circ Res 98: 540-548, 2006.